Comparing ELISA and Surface Plasmon Resonance for Assessing Clinical Immunogenicity of Panitumumab-Reference-Cited by-同舟云学术

Comparing ELISA and Surface Plasmon Resonance for Assessing Clinical Immunogenicity of Panitumumab

Published:2007-05-18 Issue:11 Volume:178 Page:7467-7472
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Lofgren James A.,Dhandapani Sripriya,Pennucci Jason J.,Abbott Christina M.,Mytych Daniel T.,Kaliyaperumal Arunan,Swanson Steven J.,Mullenix Michael C.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference12 articles.

1. Epidermal growth factor-related peptides and their receptors in human malignancies

2. Current Status of Cetuximab for the Treatment of Patients with Solid Tumors

3. Clinical experience with monoclonal antibodies to epidermal growth factor receptor

4. Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-Free Measurement of CD63 Positive Extracellular Vesicles Using Terahertz Chemical Microscopy;ACS Sensors;2024-05-24

2. Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety;The AAPS Journal;2024-04-03

3. Surface plasmon resonance as a fascinating approach in target-based drug discovery and development;TrAC Trends in Analytical Chemistry;2024-02

4. Absorption, Distribution, Metabolism and Excretion of Novel Drug Delivery Systems;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

5. Immunogenicity and Immune-Related Adverse Drug Reactions;Reference Module in Biomedical Sciences;2024